Wikidata

(Q55461000)

English

Randomized phase II trial of irinotecan and bevacizumab as neo-adjuvant and adjuvant to temozolomide-based chemoradiation compared with temozolomide-chemoradiation for unresectable glioblastoma: final results of the TEMAVIR study from ANOCEF†.

scientific article

In more languages

Statements

title
Randomized phase II trial of irinotecan and bevacizumab as neo-adjuvant and adjuvant to temozolomide-based chemoradiation compared with temozolomide-chemoradiation for unresectable glioblastoma: final results of the TEMAVIR study from ANOCEF† (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24723487
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24723487%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 March 2020
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q55461000&oldid=1612863097"